London, January 13
AstraZeneca said on Thursday that preliminary data from a trial showed that its Covid-19 shot, Vaxzevria, generated an increase in antibodies against Omicron and other variants when given as a third booster dose.
The increased response, also against the Delta variant, was seen in a blood analysis of people who were previously vaccinated with either Vaxzevria or an mRNA vaccine, the drugmaker said, adding it would submit this data to regulators worldwide given the urgent need for boosters. Lab studies conducted by the university last month already found a three-dose course of Vaxzevria boosted antibody levels in the blood against the rapidly spreading Omicron variant. — Reuters
(The article is generated from feeds via CT, The Chenab Times staff didn’t write this news.)
❤️ Support Independent Journalism
Your contribution keeps our reporting free, fearless, and accessible to everyone.
Or make a one-time donation
Secure via Razorpay • 12 monthly payments • Cancel anytime before next cycle
(We don't allow anyone to copy content. For Copyright or Use of Content related questions, visit here.)
The Chenab Times News Desk